Medicines Australia updated position on intellectual property (in light of TRIPS waiver)

6 May 2021 - Medicines Australia continues to express our sympathies to all those affected by the pandemic. The importance ...

Read more →

Australia has backed a global push to fast-track generic COVID-19 jabs

6 May 2021 - The Morrison government has joined an international push to fast-track the production of generic COVID-19 jabs, ...

Read more →

GPs to get increased supplies of COVID-19 vaccines

5 May 2021 - In a major boost to the COVID-19 vaccination program, the Australian Government is ramping up the weekly ...

Read more →

BioNTech nearing request for approval of longer lasting version of COVID vaccine

4 May 2021 - BioNTech is working on getting approval for a version of its COVID-19 vaccine which can be ...

Read more →

Pfizer says it will seek clearance in September for its vaccine to be used in children aged 2 to 11

4 May 2021 - Pfizer expects to apply to the FDA in September for emergency authorisation to administer its coronavirus ...

Read more →

Health Canada authorises use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 years of age

5 May 2021 - Today, Health Canada authorised the use of the Pfizer-BioNTech COVID-19 vaccine in children 12 to 15 ...

Read more →

How hard could it be to vaccinate the whole world? This hard.

3 May 2021 - Big-power muscle flexing helps explain much of the world’s vaccine inequities, but there's another reason behind insufficient ...

Read more →

Pfizer will file for full FDA approval by end of May

4 May 2021 - Pfizer and BioNTech, the manufacturers of one of the three authorised COVID-19 vaccines in the U.S., plan ...

Read more →

EMA starts rolling review of COVID-19 vaccine (Vero Cell) inactivated

4 May 2021 - EMA’s CHMP has started a rolling review of COVID-19 Vaccine (Vero Cell) inactivated, developed by Sinovac ...

Read more →

Doubt over local mRNA plans as major companies pull out of Australia

3 May 2021 - Vaccine development experts say it will take at least $250 million plus the support of a ...

Read more →

EMA starts evaluating use of COVID-19 vaccine Comirnaty in young people aged 12 to 15

3 May 2021 - EMA has started evaluating an application to extend the use of the COVID-19 vaccine Comirnaty to ...

Read more →

Statement from Health Canada on Janssen COVID-19 vaccines and Emergent BioSolutions

30 April 2021 - Health Canada continues to ensure the quality and safety of vaccines coming into Canada by working ...

Read more →

AstraZeneca struggles with data needed for COVID-19 vaccine’s approval

29 April 2021 - Company is assembling data for FDA review, hoping for another stamp of regulatory backing in global rollout ...

Read more →

Australia accused of delaying campaign to allow generic COVID vaccines

29 April 2021 - Australia is among a group of rich countries accused of standing in the way of some ...

Read more →

Australia has surpassed 2 million vaccines but lacks data on second doses

28 April 2021 - Australians will not be told how many people have received a second dose of the COVID-19 vaccine ...

Read more →